ESC Premium Access

Monocyte chemoattractant protein-1 level and (-75)G/A polymorphism of APOA1 gene predict response and resistance to intensive statin therapy in very high cardiovascular risk patients.

Presentation

About the speaker

Professor Svetlana Villevalde

National medical research centre named after Almazov, Saint Petersburg (Russian Federation)
0 follower

7 more presentations in this session

Effects of empagliflozin on cardiac and vascular hemodynamic markers by subgroups of age, sex and hypertension in patients with T2DM and high CV risk: EMPA-reg outcome.

Speaker: Doctor O. Johansen (Hovik, NO)

Thumbnail

Beneficial effect of beta-blockers on clinical outcomes persist after discontinuation in patients with ST elevation myocardial infarction?

Speaker: Assistant Professor J. Park (Suwon, KR)

Thumbnail

Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

Speaker: Doctor G. Hovingh (Amsterdam, NL)

Thumbnail

Riociguat ameliorates right ventricular function in patients with pulmonary hypertension.

Speaker: Assistant Professor M. Murata (Kanagawa, JP)

Thumbnail

The beneficial effects of renin angiotensin system blockades on two years outcomes in coronary artery ectasia patients

Speaker: Doctor Y. Wang (Beijing, CN)

Thumbnail

Access the full session

Optimising cardiovascular pharmacotherapy

Speakers: Professor S. Villevalde, Doctor O. Johansen, Assistant Professor J. Park, Doctor G. Hovingh, Assistant Professor M. Murata...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk